Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia

American Journal of Physiology

Volumn 271, Issue 6 PART 2, 1996, Pages

  Ortiz Arduan, Alberto ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Apoptosis; Fas; Fas ligand; Kidney; Lipopolysaccharides; Mesangium

Indexed keywords

FAS ANTIGEN; LIPOPOLYSACCHARIDE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; ENDOTOXEMIA; GLOMERULUS FILTRATION RATE; KIDNEY INJURY; LIGAND BINDING; MESANGIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; CYTOKINES; ENDOTOXEMIA; FAS LIGAND PROTEIN; KIDNEY; LIGANDS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; REFERENCE VALUES; RNA, MESSENGER;

EID: 0030460595     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.6.f1193     Document Type: Article

References (46)

1. Abboud, H. E. Growth factors in glomerulonephritis. Kidney Int. 43: 252-267,1993.
2. Alderson, M. R., B. J. Armitage, E. Maraskovsky, T. W. Tiugh, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235,1993.
3. Cheng, J., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P. J. Barr, and J. D. Mountz. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule. Science Wash. DC 263:1759-1762,1994.
4. Chu, J. L., J. Drappa, A. Parnassa, and K. B. Elkon. The defect in Fas mRNA expression in MRL Ipr/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178: 723-730,1993.
5. Clement, M. V., and I. Stamenkovic. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180: 557-567,1994.
6. Coles, H. S. R., J. F. Burne, and M. C. Raff. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784,1993.
7. De Kossodo, S., B. Critico, and G. E. Grau. Modulation of the transcripts for tumor necrosis factor-alpha and its receptors in vivo. Eur. J. Immunol. 24: 769-762,1994.
8. Drappa, J., N. Brot, and K. B. Elkon. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphopcytes in normal mice but not in the lupus-prone strain MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90: 10340-10344,1993.
9. Giroir, B. T., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693-698,1992.
10. Gottschall, A., L. Boise, C. Thompson, and J. Quintans. Identification of immunosuppresant-induced apoptosis in a murine B-cell line and its prevention by Bcl-X but not Bcl-2. Proc. Natl. Acad. Sci. USA 91: 7350-7354,1994.
11. Harel, Y., M. Suva, B. Giroir, A. Weinberg, T. B. Cleary, and B. Beutler. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. J. Clin. Invest. 92: 2110-2116,1993.
12. Haverty, T. P., C. J. Kelly, W. H. Hines, P. S. Amenta, M. Watanabe, R. A. Harper, N. A. Kefalides, and E. G. Neilson. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 107:1359-68,1988.
13. Itoh, N., and S. Nagata. A novel domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932-10937,1993.
14. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. The polypeptide encoded by the cDNAfor human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243,1991.
15. Johnson, R. J., J. Floege, W. G. Couser, and C. E. Alpers. Role of platelet-derived growth factor in glomerular disease. J. Am. Soc. Nephrol. 4:119-128,1993.
16. Kalluri, R., S. Gunwar, S. T. Reeders, K. C. Morrision, M. Mariyama, K. E. Ebner, M. E. Noelken, and B. G. Hudson. Goodpasture syndrome: localization of the epitope for the autoantibodies to the carboxyl-terminal region of the a3(IV) chain of basement membrane collagen. J. Biol. Chem. 266:24018-24024,1991.
17. Kelly, C. J., D. A. Roth, and C. M. Meyers. Immune recognition and response to the renal interstitium. Kidney Int. 31: 518-530,1991.
18. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88: 2830-2834, 1991.
19. Mapara, M. Y., R. Bargou, C. Zugek, H. Dohner, F. Ustaoglu, R. R. Jonker, P. H. Krammer, and B. Dorken. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Ear. J. Immunol. 23: 702-708,1993.
20. Martin, S. J., D. R. Green, and T. G. Cotter. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biol. Sci. 19: 26-30,1994.
21. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758,1992.
22. Neilson, E. G., R. Kalluri, M. J. Sun, S. Gunwar, T. Danoff, M. Mariyama, J. C. Myers, S. T. Reeders, and B. G. Hudson. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J. Biol. Chem. 268: 8402-5,1993.
23. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponsting, and P. H. Krammer. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267: 10709-10715,1992.
24. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugal, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809,1993.
25. Olsen, S., J. F. Burdick, P. A. Keown, A. C. Wallace, L. C. Racussen, and K. Solez. Primary acute renal failure (acute tubular necrosis) in the transplanted kidney: morphology and pathogenesis. Medicine Baltimore 68:173-187,1989.
26. Ortiz, A., M. Gomez-Chiarri, J. Alonso, C. Bustos, C. GomezGuerrero, M. J. Lopez-Armada, D. Gomez-Garre, I. Palacios, M. Ruiz-Ortega, S. Gutierrez, and et al. The potential role of inflammatory mediators and fibrogenic cytokines in the pathogenesis of glomerular diseases. J. Lipid Med. 9:55-74,1994.
27. Owen-Schaub, L. B., R. Radinsky, E. Kruzel, K. Berry, and, S. Yonahara Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54: 1580-1586,1994.
28. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Stelmetz, and H. Bluethmann. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. JVaiKreLoreci 364: 798-802, 1993.
29. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200,1993.
30. Sato, T., S. We, S. Kitada, and J. C. Reed. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science Wash. DC 268: 411-415,1995.
31. Schumer, M., M. C. Colombel, I. S. Sawczuk, G. Gobe, J. Connor, K. M. Otoole, C. A. Olsson, G. J. Wise, and R. Buttyan. Morphologic, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 140: 831-838,1992.
32. Shimizu, A., H. Kitamura, Y. Masuda, M. Ishizaki, Y. Sugisaki, and N. Yamanaka. Apoptosis in repair process of experimental mesangioproliferative glomerulonephritis (Abstract). J. Am. Soc. Nephrol. 4: 633,1993.
33. Smith, C. A., T. Farrah, and R. G. Goodwin. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and cell death. Cell 76: 959-962,1994.
34. Stalder, T., S. Hahn, and P. Erb. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol. 152: 1127-1133,1994.
35. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178,1993.
36. Takahashi, T., M. Tanak, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. S. Suda, and S. Nagata. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976,1994.
37. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goedel. A novel domain within the 55kd TNF receptor signals cell death. Cell 74: 845-853,1993.
38. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Moller, W. Falk, K. M. Debatin, and P. H. Krammer. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science Wash. DC 245: 301-305,1989.
39. Tsujimoto, M., Y. K. Yip, and J. Vilcek. Interferon-/ enhances expression of cellular receptors for tumor necrosis factor. J. Immunol. 136: 2441-2444, 1986.
40. Verstrepen, W. A., E. J. Nouwen, X. S. Yue, and M. E. De Broe. Altered growth factor expression during proximal tubular necrosis and regeneration. Kidney Int. 43:1267-1279,1993.
41. Wang, S. D., K. J. Huang, Y. S. Lin, and H. Y. Lei. Sepsis induced apoptosis of thymocytes in mice. J. Immunol. 152: 5014-21,1994.
42. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. The cDNA structure, expression, and chromosomal assignment of the mouse fas antigen. J. Immunol. 148: 1274-1279,1992.
43. Weiss, R. A., M. P. Madaio, J. E. Tomaszewski, and C. J. Kelly. T cells reactive to an inducible heat shock protein induce disease in a model of toxin-induced interstitial nephritis. J. Exp. Med. 180: 1994.
44. Wolf, G., U. Haberstroh, and E. G. Neilson. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 140:95-107,1992.
45. Wong, G. H. W, and D. V. Goeddel. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751-1755,1994.
46. Yonehara, S., A. Ishi, and M. Yonehara. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down regulated with the receptor of TNF. J. Exp. Med. 169:1747-1756,1989.